Boston Scientific Corp (BSX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2015 | 12-2014 | 09-2014 | 06-2014 | 03-2014 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 242,000 | 587,000 | 246,000 | 357,000 | 191,000 |
| Receivables | 1,161,000 | 1,183,000 | 1,233,000 | 1,287,000 | 1,217,000 |
| Inventories | 958,000 | 946,000 | 989,000 | 949,000 | 926,000 |
| Income taxes - deferred | 339,000 | 447,000 | 303,000 | 320,000 | 279,000 |
| Other current assets | 489,000 | 443,000 | 0 | 0 | 0 |
| TOTAL | $3,189,000 | $3,606,000 | $3,175,000 | $3,214,000 | $2,936,000 |
| Non-Current Assets | |||||
| PPE Net | 1,458,000 | 1,507,000 | 1,522,000 | 1,534,000 | 1,539,000 |
| Intangibles | 11,395,000 | 11,504,000 | 11,633,000 | 11,394,000 | 11,499,000 |
| Other Non-Current Assets | 430,000 | 407,000 | 388,000 | 335,000 | 361,000 |
| TOTAL | $13,283,000 | $13,418,000 | $13,543,000 | $13,263,000 | $13,399,000 |
| Total Assets | $16,472,000 | $17,024,000 | $16,718,000 | $16,477,000 | $16,335,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 423,000 | 403,000 | 3,000 | 3,000 | 4,000 |
| Accounts payable and accrued liabilities | 228,000 | 262,000 | 234,000 | 241,000 | 241,000 |
| Accrued Expenses | 1,512,000 | 1,950,000 | 1,288,000 | 1,277,000 | 1,275,000 |
| Other current liabilities | 300,000 | 231,000 | 295,000 | 252,000 | 199,000 |
| TOTAL | $2,463,000 | $2,846,000 | $1,820,000 | $1,773,000 | $1,719,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 3,845,000 | 3,841,000 | 4,249,000 | 4,252,000 | 4,245,000 |
| Other Non-Current Liabilities | 2,700,000 | 2,666,000 | 2,724,000 | 2,606,000 | 2,398,000 |
| TOTAL | $7,508,000 | $7,721,000 | $8,197,000 | $8,160,000 | $8,082,000 |
| Total Liabilities | $9,971,000 | $10,567,000 | $10,017,000 | $9,933,000 | $9,801,000 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,340,676 | 1,330,512 | 1,326,490 | 1,325,708 | 1,322,676 |
| Common Shares | 16,000 | 16,000 | 16,000 | 16,000 | 16,000 |
| Retained earnings | -8,690,000 | -8,689,000 | -8,389,000 | -8,432,000 | -8,436,000 |
| Other shareholders' equity | 142,000 | 144,000 | 110,000 | 42,000 | 72,000 |
| TOTAL | $6,501,000 | $6,457,000 | $6,701,000 | $6,544,000 | $6,534,000 |
| Total Liabilities And Equity | $16,472,000 | $17,024,000 | $16,718,000 | $16,477,000 | $16,335,000 |